Tracking how a new injectable treatment works for inflammatory bowel disease

This is a real-world study of vedolizumab, an injectable medication used to treat moderate to severe ulcerative colitis and Crohn's disease. Researchers will follow approximately 600 patients in South Korea over one year to observe how well the medication works and whether it is safe when used in regular medical clinics. The study is designed to gather information about how the treatment performs outside of controlled research settings.

Many people with inflammatory bowel disease don't respond well to older treatments or can't tolerate them. This study exists to understand whether this medication is truly effective and safe for patients in real-world conditions, which can be different from controlled research environments.